# DESCRIPTION

## FIELD OF THE INVENTION

- relate to mmBCFA discovery

## BACKGROUND OF THE INVENTION

- introduce fatty acids
- describe mmBCFA in bacteria
- describe mmBCFA in eukaryotes
- discuss mmBCFA functions
- discuss mmBCFA biosynthesis
- highlight knowledge gaps

## SUMMARY OF THE INVENTION

- introduce non-human animal model
- describe protein modifications
- introduce isolated cell model
- describe cell modifications
- introduce method to identify compounds
- describe compound identification
- introduce method to regulate mmBCFA
- describe compound detection
- introduce method to identify compounds
- describe compound detection
- introduce method to regulate mmBCFA
- describe compound detection
- introduce method to identify compounds
- describe compound detection
- introduce method to regulate mmBCFA
- describe compound detection
- introduce method to identify compounds
- describe compound detection
- introduce method to regulate mmBCFA
- describe compound detection
- introduce method to identify compounds
- describe compound detection
- introduce method to regulate mmBCFA
- describe compound detection
- introduce method to identify compounds
- describe compound detection
- introduce method to regulate mmBCFA
- describe compound detection
- introduce formulation
- describe formulation composition
- introduce method to increase mmBCFA

## DETAILED DESCRIPTION OF THE INVENTION

- introduce mmBCFA in eukaryotes
- describe biosynthesis of mmBCFA in C. elegans
- show essentiality of mmBCFA for C. elegans growth and development
- describe mmBCFA with different length carbon backbones
- show correlation between mmBCFA supplement and rescue ability
- describe ACS-1 requirement for embryogenesis
- show genetic interaction between zen-4 and acs-1
- describe effect of ACS-1 on eggshell and adult cuticle formation
- show relationship between mmBCFA and DAF pathway
- describe genetic interaction between acs-1 and DAF-2/DAF-16 pathway
- show effect of mmBCFA deficiency on DAF-16 nuclear translocation
- describe connection of mmBCFA to insulin-signaling pathway
- show effect of mmBCFA deficiency on dauer formation
- describe link between mmBCFA biosynthesis and protein uptake
- show transcriptional suppression of elo-5 by TOR pathway
- describe effect of exogenous mmBCFA on pnk-1 expression
- show negative feedback control of pnk-1 by mmBCFA
- describe role of mmBCFA in coordination of food signaling and energy expenditure
- show elongation of C13ISO into C15ISO and C17ISO in mammalian cells
- describe identification of key enzymes and regulatory proteins in mmBCFA biosynthesis
- show potential feedback regulation of mmBCFA biosynthesis
- describe involvement of SREBP and pantothenate kinase in mmBCFA biosynthesis
- show elo-5 and elo-6 as targets of LPD-1
- describe physiological roles of C13ISO, C15ISO, and C17ISO
- show biological activity of mmBCFA methyl esters
- describe use of mmBCFA methyl esters as food supplements
- show better solubility and permeability of mmBCFA methyl esters
- describe absorption of dietary mmBCFA by animal cells
- show incorporation of mmBCFA into lipid fractions
- describe lack of toxic effect of mmBCFA in eukaryotic organisms
- show extraction of mmBCFA from bacterial species
- describe use of mmBCFA-carrying bacteria as sources of mmBCFA
- show use of fatty acid methyl esters in various applications
- describe potential physiological value of mmBCFA methyl esters
- show anteISO branched-chain FA physiological potency
- describe model system for identifying regulators of mmBCFA
- show modification of mmBCFA biosynthetic pathway components
- describe evaluation of effects of modification on mmBCFA biosynthesis
- show use of organisms with intact mmBCFA biosynthesis capacity
- describe evaluation of effects of putative regulators on mmBCFA biosynthesis
- show use of functional and non-functional mmBCFA systems
- describe modification of organisms to produce mmBCFA
- show use of bacterial cells and eukaryotic organisms
- describe genetic modification of organisms
- show deletion or inactivation of proteins involved in mmBCFA biosynthesis
- describe use of RNA interference to modify mmBCFA biosynthesis
- show feeding of RNAi to C. elegans to disrupt mmBCFA biosynthesis
- describe use of invertebrate systems to elucidate biochemical pathways
- show use of SREBP expression system to screen for regulators of mmBCFA biosynthesis
- describe combination of mmBCFA-related genetic engineering and dietary supplements
- introduce mmBCFA system
- describe mmBCFA biosynthesis and metabolism
- relate mmBCFA to growth, development, and reproduction
- introduce methods to evaluate pharmaceutical and nutraceutical compounds
- describe targets for pharmaceutical and nutraceutical compounds
- introduce long chain fatty acid elongation enzymes ELO-5 and ELO-6
- describe ELO-5 and ELO-6 biological activity
- introduce mmBCFA-specific acetyl-CoA synthetase ACS-1
- describe ACS-1 biological activity
- introduce lipid depleted 1 LPD-1
- describe LPD-1 biological activity
- introduce nuclear hormone receptor 49 NHR-49
- describe NHR-49 biological activity
- introduce RuvB-like DNA binding protein
- describe RuvB-like DNA binding protein biological activity
- introduce pantothenate kinase PNK-1
- describe PNK-1 biological activity
- introduce branched-chain Î±-keto-acid dehydrogenase BCKAD
- describe BCKAD biological activity
- introduce oligopeptide transporter PEP-2
- describe PEP-2 biological activity
- introduce phosphoinositide-dependent protein kinase 1 PDK-1
- describe PDK-1 biological activity
- introduce DAF-2 insulin receptor
- describe DAF-2 biological activity
- introduce POD-1
- describe POD-1 biological activity
- introduce SOD-3
- describe SOD-3 biological activity
- introduce ZEN-4
- describe ZEN-4 biological activity
- relate targets to mmBCFA biosynthesis and function
- describe structural homologues of targets
- introduce methods for identifying therapeutic or nutraceutical compounds
- describe identifying regulators of target genes
- introduce WormBase database
- describe information in WormBase database
- introduce accession numbers
- describe information in accession numbers
- relate targets to other organisms
- conclude mmBCFA biosynthesis and function
- describe DAF-2 component
- describe DAF-2 function
- describe DAF-2 homologues
- describe ZEN-4 component
- describe ZEN-4 function
- describe ZEN-4 homologues
- describe POD-1 component
- describe POD-1 function
- describe POD-1 homologues
- describe SOD-3 component
- describe SOD-3 function
- describe SOD-3 homologues
- describe gene fragments
- describe regulation of target genes
- describe regulation of mmBCFA biosynthesis
- describe evaluation of target genes
- describe knock-out methods
- describe nucleic acid-based experiments
- describe identification of additional pathway members
- describe scope of invention
- describe methods for identifying regulatory compounds
- describe screening and selecting compounds
- describe regulation of target genes
- describe evaluation of compounds
- describe biological activity of proteins and lipids
- describe biologically active fragments or homologues
- introduce modified non-human organism
- describe gene modification methods
- list proteins involved in mmBCFA biosynthesis and function
- define mimetic
- describe methods for designing and selecting mimetics
- introduce molecular diversity strategy
- describe methods of directed design
- describe methods of random design
- describe grid-based approach
- define test compound
- describe method for identifying regulatory compounds
- describe cell-based assay conditions
- describe culturing conditions
- define expression
- describe methods for detecting expression
- describe method for identifying additional genes associated with mmBCFA biosynthesis
- describe method for regulating mmBCFA metabolism and homeostasis
- describe method for regulating growth, development, and reproduction
- describe method for regulating food sensing and insulin signaling
- describe pharmaceutical, nutraceutical, and dietary compositions
- describe pharmaceutically acceptable carriers
- describe formulation methods
- describe administration routes
- describe food products for oral administration
- describe method for achieving a desired physiological effect
- describe patient populations
- define therapeutic benefit
- define protected from a disease
- describe Maple Syrup Urine Disease (MSUD)
- describe conventional treatment for MSUD
- describe dietary supplementation with long chain mmBCFA for MSUD
- describe dietary supplement composition
- describe pharmaceutical composition
- describe nutraceutical composition
- describe additional components for compositions
- define isolated protein
- describe methods for producing isolated proteins
- describe smaller peptides as regulatory peptides
- describe synthetic production of peptides
- describe method for identifying compounds that regulate mmBCFA biosynthesis
- describe method for identifying compounds that regulate mmBCFA function
- describe method for identifying compounds that regulate mmBCFA metabolism
- describe method for identifying compounds that regulate mmBCFA homeostasis
- describe method for identifying compounds that regulate growth, development, and reproduction
- describe method for identifying compounds that regulate food sensing and insulin signaling
- describe method for identifying compounds that regulate mmBCFA biosynthetic and metabolic pathway
- describe method for identifying compounds that regulate physiological processes related to mmBCFA
- describe method for identifying compounds that regulate mmBCFA and its derivatives
- describe method for identifying compounds that regulate fatty acid composition
- describe method for identifying compounds that regulate ratios and compositions of different fatty acids
- describe gas chromatography analysis of FA composition
- describe method for modifying total fatty acid profile
- describe method for manipulating mmBCFA in an organism
- describe method for regulating mmBCFA biosynthesis and function
- describe method for regulating mmBCFA metabolism and homeostasis
- define homologue
- describe agonist
- describe antagonist
- define isolated nucleic acid molecule
- describe production of isolated nucleic acid molecule
- describe recombinant vector
- describe expression vector
- describe targeting vector
- describe recombinant nucleic acid molecule
- describe transfection
- describe transformation
- describe hybridization
- describe stringent hybridization conditions
- describe moderately stringent conditions
- describe high stringency conditions
- describe very high stringency conditions
- calculate melting temperature
- describe wash conditions
- describe amino acid sequence with heterologous amino acids
- describe nucleic acid sequence with heterologous nucleotides
- define percent identity
- describe BLAST 2.0 Basic BLAST homology search
- describe BLAST 2 alignment
- describe PSI-BLAST
- describe BLAST 2 sequence alignment
- describe parameters for blastn
- describe parameters for blastp
- introduce experimental results
- describe first experiment
- describe second experiment
- describe third experiment
- describe fourth experiment
- describe fifth experiment
- describe sixth experiment
- describe seventh experiment
- describe eighth experiment
- describe ninth experiment
- describe tenth experiment
- describe eleventh experiment
- describe twelfth experiment
- describe thirteenth experiment
- describe fourteenth experiment
- describe fifteenth experiment
- describe sixteenth experiment
- describe seventeenth experiment
- describe eighteenth experiment
- describe nineteenth experiment
- describe twentieth experiment
- describe twenty-first experiment
- describe twenty-second experiment
- conclude experimental results

### EXAMPLES

- describe unexpected physiological functions
- introduce RNA interference by feeding
- describe RNAi feeding vectors
- explain RNAi feeding strain preparation
- describe synchronized worm plating
- introduce gas chromatography analysis
- describe fatty acid methyl esters and lipid extraction
- explain GC analysis
- describe staging worms for FA composition testing
- introduce phenotype rescue using FA supplements
- describe elo-5(RNAi) worm rescue
- introduce designing of GFP reporter constructs
- describe elo-5Prom::GFP construct
- describe elo-6Prom::GFP construct
- describe acs-1Prom::GFP construct
- describe pnk-1Prom::GFP construct
- introduce staining chemosensory ciliated neuron with DiI
- describe correlation analysis
- introduce visualization and scoring of GFP expression
- describe microarray analysis
- introduce array design
- describe experimental design
- introduce total RNA isolation
- describe hybridization and data processing
- introduce measurement data and specifications
- describe statistical algorithms and data manipulation
- introduce mmBCFA metabolism
- functionally test candidates by RNAi and GC analysis
- identify elo-1 and elo-2 genes affecting FA elongation
- identify elo-5 and elo-6 genes affecting branched-chain FA
- analyze elo-5 and elo-6 gene expression patterns
- show elo-5 RNAi reduces C15ISO and C17ISO levels
- show elo-6 RNAi reduces C17ISO level
- identify BCKAD complex genes in C. elegans
- show BCKAD complex genes affect mmBCFA biosynthesis
- compare mmBCFA biosynthesis in bacteria, C. elegans, and humans
- describe elo-5 RNAi phenotypes
- show elo-5 RNAi causes growth and developmental defects
- analyze elo-5 RNAi phenotypes in different larval stages
- show elo-5 RNAi phenotypes are rescued by C17ISO supplements
- show C17ISO is incorporated into lipids in rescued worms
- analyze FA composition in worms grown on supplemented plates
- show ELO-6 function remains intact in elo-5(RNAi) animals
- analyze elo-5(gk208) deletion mutant phenotypes
- show elo-5(gk208) mutant phenotypes are rescued by C17ISO supplements
- analyze L1 arrest of elo-5(RNAi) animals
- show L1 arrest is reversible by C17ISO supplements
- analyze FA levels in staged worms
- show C17ISO level increases during development
- propose relationship between C17ISO levels and developmental stages
- analyze correlation between C17ISO levels and other FA species
- show correlation between C17ISO and linoleic acid levels
- show correlation between C17ISO and vaccenic acid levels
- discuss potential physiological significance of correlations
- analyze FA composition in elo-5(RNAi) worms
- calculate saturation index in elo-5(RNAi) worms
- discuss potential common function of C17ISO and linoleic acid
- analyze FA composition in elo-5(RNAi) worms fed with S. maltophilia
- show mmBCFA become principal components in FA composition
- discuss potential cross-regulation of mmBCFA and straight-chain FA
- introduce worm SREBP homology
- describe control of branched-chain FA production by SREBP
- conclude significance of mmBCFA in C. elegans development
- introduce FA biosynthesis in mammals
- introduce SREBP-1c and its role in FA biosynthesis
- introduce C. elegans homolog of SREBP-1c, LPD-1
- describe LPD-1's role in FA biosynthesis
- describe RNAi experiment to test LPD-1's role in mmBCFA biosynthesis
- describe results of RNAi experiment
- introduce LPD-2 and its role in FA biosynthesis
- compare LPD-1 and LPD-2 functions
- introduce elo-5 and elo-6 as likely targets of LPD-1
- describe GFP reporter analysis to test elo-5 and elo-6 regulation
- describe results of GFP reporter analysis
- test if disruption of FAS contributes to mmBCFA deficiency
- describe results of FAS RNAi experiment
- conclude that LPD-1 regulates mmBCFA biosynthesis
- introduce reciprocal correlation between LPD-1 expression and mmBCFA levels
- describe microarray analysis to test LPD-1 regulation by mmBCFA
- describe results of microarray analysis
- test LPD-1 regulation by mmBCFA in amphid neurons
- describe results of LPD-1 regulation in amphid neurons
- introduce screening for additional genes involved in mmBCFA homeostasis
- describe microarray analysis to identify candidate genes
- describe selection criteria for candidate genes
- introduce four candidate genes involved in mmBCFA homeostasis
- describe RNAi analysis of candidate genes
- describe results of RNAi analysis
- analyze candidate genes for feedback regulation of mmBCFA biosynthesis
- describe reporter strains to test acs-1 and pnk-1 regulation
- describe results of reporter strain analysis
- discuss potential link to DAF-2/insulin signaling
- introduce C27H6.2 as a potential regulator of monounsaturated FA levels
- describe potential adaptive effect of C27H6.2 down-regulation
- conclude importance of mmBCFA for growth and development
- discuss potential regulatory role of mmBCFA on growth and development
- discuss potential mechanisms of mmBCFA action
- introduce potential for further investigation of mmBCFA biosynthesis
- introduce potential for further investigation of mmBCFA transport and signaling
- introduce potential for further investigation of mmBCFA physiological functions

### Example 2

- describe role of acs-1 in embryogenesis
- demonstrate suppression of acs-1 causes embryonic lethality
- propose model of ZEN-4 binding to ACS-1 product

### Example 3

- describe role of acs-1 in protective layer formation
- demonstrate suppression of acs-1 affects eggshell and cuticle formation
- show acs-1(RNAi)+C13ISO embryos are osmotic sensitive
- compare inner layer of eggshell in acs-1(RNAi)+C13ISO and pod-1 mutants

### Example 4

- describe role of mmBCFA and DAF pathway in food sensation and insulin signaling
- demonstrate genetic interaction between acs-1 and daf-2
- show deficiency of mmBCFA activates expression of pnk-1 and sod-3
- demonstrate deficiency of mmBCFA stimulates nuclear translocation of DAF-16
- show elo-5 is down-regulated in K01G5.1(RNAi)
- describe L1 arrest caused by mmBCFA deficiency

### Example 5

- describe correlation between mmBCFA and growth
- demonstrate C13ISO supplementation rescues elo-5(gk208) larval lethal phenotype
- show non-linear correlation between C13ISO concentration and rescue ability
- describe effects of high C13ISO concentrations on growth and maturation

### Example 6

- describe link between mmBCFA biosynthesis and protein uptake
- demonstrate RNAi of pep-2 results in slow postembryonic development
- show changes in FA composition of total lipids in pep-2(RNAi)
- demonstrate decrease in mmBCFA levels in pep-2(RNAi)
- analyze GFP expression of reporter constructs on pep-2(RNAi) background
- propose transcriptional down-regulation of elo-5 in pep-2(RNAi)

### Example 7

- demonstrate elo-5 as a down-stream target of TOR
- show effect of inhibiting ceTOR pathway on elo-5 expression

### Example 8

- describe effect of exogenous mmBCFA on pantothenate kinase gene expression
- demonstrate down-regulation of pnk-1 by high levels of mmBCFA
- propose link between CoA metabolism and mmBCFA

### Example 9

- demonstrate human cells can elongate exogenous short chain mmBCFA

